GlassScriptPhysician profile
Michael Cameron Sweeney
NPI 1396943114
$4,604.25
in general payments reported to CMS, 2019-2025
36 companies · $651 in 2025
The $651 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $115 · 2021: $80.37 · 2022: $695 · 2023: $2,176 · 2024: $605 · 2025: $651.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,132 · Travel and Lodging: $1,301.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,132.03 |
| Travel and Lodging | $1,300.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,625.00 | 2022-2023 | Aquabeam Robotic System |
| Cook Medical LLC | $482.93 | 2025 | Litho 150 |
| Astellas Pharma US INC | $430.49 | 2019-2024 | Myrbetriq, Xtandi, Veozah |
| Sumitomo Pharma America, INC. | $243.52 | 2023-2025 | Orgovyx, Myfembree |
| Dornier Medtech America, INC | $171.24 | 2022 | |
| Urovant Sciences INC | $128.15 | 2022 | |
| 180 Medical, INC. | $126.52 | 2021-2025 | |
| Coloplast Corp | $123.18 | 2023-2024 | Speedicath, Porges Coloplast |
| Pfizer INC. | $116.20 | 2022-2025 | |
| Myovant Sciences INC. | $97.78 | 2021-2022 | |
| Progenics Pharmaceuticals, INC. | $96.84 | 2023-2024 | Pylarify |
| Baxter Healthcare | $86.47 | 2022-2024 | Tisseel, Floseal, Seprafilm |
| Boston Scientific Corporation | $79.60 | 2019-2022 | |
| C. R. Bard, INC. & Subsidiaries | $74.88 | 2024 | Bard Urinary Drainage Bag |
| Abbvie INC. | $73.60 | 2019-2023 | Lupron Depot |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $67.76 | 2023-2024 | Bridion |
| Tolmar Pharmaceuticals, INC. | $66.13 | 2019-2022 | |
| Janssen Biotech, INC. | $62.23 | 2020-2024 | Erleada, Balversa, Akeega |
| Emd Serono, INC. | $54.55 | 2023 | Bavencio |
| Becton, Dickinson and Company | $52.22 | 2024 | Arista Ah Flexitip |
| Convatec INC. | $50.53 | 2025 | |
| Endo Pharmaceuticals INC. | $37.29 | 2019 | |
| Axonics, INC. | $30.09 | 2022 | |
| Intuitive Surgical, INC. | $28.98 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $22.80 | 2025 | Imfinzi |
| Immunitybio, INC. | $20.35 | 2025 | |
| Smith+Nephew, INC. | $17.92 | 2023 | Stravix Pl |
| E.R. Squibb & Sons, L.L.C. | $17.35 | 2024 | Opdivo |
| Laborie Medical Technologies Corp. | $17.19 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $16.48 | 2025 | |
| Myriad Genetic Laboratories, INC. | $16.19 | 2024 | Prolaris |
| Ferring Pharmaceuticals INC. | $15.38 | 2024 | Adstiladrin |
| Teleflex LLC | $14.71 | 2023 | Urolift |
| Bayer Healthcare Pharmaceuticals INC. | $13.71 | 2022 | |
| Tolmar, INC. | $13.59 | 2023 | |
| Allergan, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.